Biogen Idec, Samsung launch biosimilars JV

Biogen Idec Inc. (NASDAQ:BIIB) and Samsung Group (Seoul, South Korea) launched biosimilars JV Samsung Bioepis Co. Ltd. and named Christopher Hansung Ko as its CEO. He was previously SVP of Samsung str...